Efficacy and safety of dapagliflozin over 1 year as add‐on to insulin therapy in Japanese patients with type 2 diabetes: the DAISY (Dapagliflozin Added to patients under InSulin therapY) trial
Eiichi Araki; Yukiko Onishi; Michiko Asano; Hyosung Kim; Toshitaka Yajima
Author Information: Department of Metabolic Medicine, Faculty of Life Sciences
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.